Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangyaoda Technology is a leading Chinese biotechnology company specializing in the development of single-cell and spatial multi-omics technologies. The company is recognized for its proprietary automated systems designed for single-cell sequencing library preparation and high-throughput spatial transcriptomics. Their flagship products aim to standardize complex genomic workflows, reducing manual labor and enhancing the reproducibility of research data. Guangyaoda provides end-to-end solutions, including specialized reagents, automated workstations, and bioinformatics software, to support academic and clinical researchers. By focusing on high-resolution cellular mapping, the company facilitates advancements in drug discovery, precision medicine, and basic life science research. They primarily serve the oncology, immunology, and regenerative medicine sectors within the global scientific community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangyaoda Technology.